XML 23 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
12 Months Ended
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Net loss $ (126,503) $ (32,848) $ (12,713)
Depreciation 121,644 119,441 125,426
Amortization 14,554 12,057 3,981
Straight-line rent adjustments 1,989 2,686 2,602
Provision for doubtful accounts 2,461 1,763 1,357
Lease Termination Revenue Non Cash (4,200)    
Insurance Recoveries (689)    
Amortization of deferred compensation 6,925 5,709 6,035
Loss on hedge ineffectiveness 0 0 143
Gain on sales of interests in real estate and non-operating real estate, net (9,625) (909) (23,402)
Equity in income of partnerships (11,375) (14,367) (18,477)
Equity Method Investment, Realized Gain (Loss) on Disposal (2,772) (6,539) 0
Proceeds from Equity Method Investment, Distribution 9,421 16,849 22,094
Amortization of historic tax credits 829 1,768 1,768
Impairment of real estate assets 129,365 55,793 62,603
Impairment of mortgage note receivable 8,122    
Net change in other assets 5,998 5,652 (4,566)
Net change in other liabilities 6,352 (4,752) (12,312)
Net cash provided by operating activities 134,864 142,091 154,931
Payments to Acquire Commercial Real Estate 17,611 0 0
Cash proceeds from sales of real estate 13,730 77,778 154,758
Proceeds from Insurance Settlement, Investing Activities 700    
Proceeds from Sale of Equity Method Investments 19,727 30,265  
Proceeds from (Payments for) Other Financing Activities 123,000 35,221  
Additions to construction in progress 75,649 116,550 88,161
Investments in real estate improvements 35,170 51,949 49,942
Additions to leasehold improvements and corporate fixed assets 160 683 522
Investments in equity method investees 58,112 73,434 14,910
Capitalized leasing costs 12,022 6,066 6,101
Net cash used in investing activities (41,567) (105,418) (4,878)
Proceeds from Issuance of Preferred Stock and Preference Stock 0 286,847  
Repayments under revolving facilities (12,000) (56,000) (82,000)
Proceeds from mortgage loans 10,185 0 139,000
Repayment of mortgage loans 0 150,000 280,327
Principal installments on mortgage loans 18,655 17,945 17,868
Payment of deferred financing costs 5,529 71 3,337
Value of shares of beneficial interest issued 1,410 2,085 1,288
Dividends paid to common shareholders 59,145 58,651 58,372
Dividends paid to preferred shareholders 27,375 27,403 15,848
Distributions paid to Operating Partnership unit holders and noncontrolling interest 6,949 6,970 6,991
Value of shares retired under equity incentive plans, net of shares issued 747 1,477 2,177
Redeemable Noncontrolling Interest, Equity, Preferred, Redemption Value 0 (115,000)  
Net cash used in financing activities (94,805) (32,585) (162,632)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (1,508) 4,088 (12,579)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (1,508) 4,088 (12,579)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 32,445 $ 33,953 $ 29,865